Minimed GroupMMED +0.14%15 PB Ratio is 1.16 as of Jun. 27, 2026, which is 1% above its 10-year median of 1.15. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 788 Medical Devices & Instruments companies, Minimed Group ranks better than 75.13% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Minimed Group's share price is $14.28. Minimed Group's Book Value per Share for the quarter that ended in Jan. 2026 was $12.33. Hence, Minimed Group's PB Ratio of today is 1.16.
The historical rank and industry rank for Minimed Group's PB Ratio or its related term are showing as below:
MMED'
s PB Ratio Range Over the Past 10 Years
Min: 0.88 Med: 1.15 Max: 1.5
Current: 1.16
During the past 3 years, Minimed Group's highest PB Ratio was 1.50. The lowest was 0.88. And the median was 1.15.
MMED's PB Ratio is ranked better than 75.13% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs MMED: 1.16
During the past 12 months, Minimed Group's average Book Value Per Share Growth Rate was -3.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Minimed Group PB Ratio Related Terms
Minimed Group PB Ratio Historical Data
* Premium members only.
The historical data trend for Minimed Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group PB Ratio Chart
Minimed Group Annual Data
Trend
Apr23
Apr24
Apr25
PB Ratio
0.00
0.00
0.00
Minimed Group Quarterly Data
Apr24
Jan25
Apr25
Oct25
Jan26
PB Ratio
0.00
0.00
0.00
0.00
0.00
MMED vs ICUI, WRBY, MMSI: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Minimed Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minimed Group PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Minimed Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Minimed Group's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Minimed Group (MMED) has a PB Ratio of 1.16 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Minimed Group and its competitors. This is near median its historical median of 1.15. Over the past decade, Minimed Group's PB Ratio has ranged from 0.88 to 1.50. According to the industry distribution chart, Minimed Group ranks #196 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 24.9%.
Is Minimed Group's PB Ratio too high?
Minimed Group's current PB Ratio of 1.16 is near median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 1.50. The Medical Devices & Instruments industry median PB Ratio is 2.02. Minimed Group's value of 1.16 is 42.6% below this industry median. Based on the distribution chart, Minimed Group ranks #196 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's PB Ratio compare to ICUI and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Minimed Group ranks #196 out of 788 companies for PB Ratio. This places Minimed Group in the top 25% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. Minimed Group's value of 1.16 is 42.6% below this benchmark. Historically, Minimed Group's own PB Ratio has ranged from 0.88 to 1.50 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 2.02, Minimed Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Minimed Group's current PB Ratio of 1.16 is 42.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Minimed Group and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minimed Group's current PB Ratio is 1.16, which is near median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current PB Ratio of 1.16. The current PB Ratio is 1.16, which is near median its 10-year median of 1.15 and 42.6% below the Medical Devices & Instruments industry median of 2.02. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Minimed Group (MMED), the current PB Ratio is 1.16 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score
Get the complete analysis for MMED
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMED has been successfully added to your 